ClearOne Jumps on Planned Cortigent Reverse-Merger Deal

ClearOne (CLRO) is up 114.0% today. Here is some analysis on what might have caused this price movement. ([globenewswire.com](https://www.globenewswire.com/news-release/2026/07/02/3321264/0/en/vivani-announces-entry-into-merger-agreement-between-wholly-owned-subsidiary-cortigent-inc-and-nasdaq-listed-clearone-inc.html))

Analysis: The sharp move appears tied to ClearOne’s merger agreement with Cortigent, a neurostimulation and brain-computer-interface device developer currently owned by Vivani Medical. Investors may be reacting to ClearOne’s planned transformation from a largely inactive public shell into a medical-device company with a new name, new ticker, and fresh financing tied to the deal. ([globenewswire.com](https://www.globenewswire.com/news-release/2026/07/02/3321264/0/en/vivani-announces-entry-into-merger-agreement-between-wholly-owned-subsidiary-cortigent-inc-and-nasdaq-listed-clearone-inc.html))

Details:

ClearOne agreed to merge with Cortigent, and the surviving public company is expected to be renamed Cortigent Holdings and trade under the ticker CRGT. ([globenewswire.com](https://www.globenewswire.com/news-release/2026/07/02/3321264/0/en/vivani-announces-entry-into-merger-agreement-between-wholly-owned-subsidiary-cortigent-inc-and-nasdaq-listed-clearone-inc.html))

The transaction includes a concurrent financing plan in which ClearOne would raise between $10 million and $15 million at closing, which could help fund product development. ([globenewswire.com](https://www.globenewswire.com/news-release/2026/07/02/3321264/0/en/vivani-announces-entry-into-merger-agreement-between-wholly-owned-subsidiary-cortigent-inc-and-nasdaq-listed-clearone-inc.html))

Vivani is expected to own roughly 59.4% to 67.5% of the combined company, while former ClearOne shareholders are expected to own about 12.7% to 14.4%, highlighting that the deal is effectively a reverse-merger style recapitalization. ([globenewswire.com](https://www.globenewswire.com/news-release/2026/07/02/3321264/0/en/vivani-announces-entry-into-merger-agreement-between-wholly-owned-subsidiary-cortigent-inc-and-nasdaq-listed-clearone-inc.html))

ClearOne had already disclosed that, after selling substantially all operating assets, it was evaluating strategic alternatives and positioning itself as a reverse merger vehicle, so today’s announcement fits that plan. ([sec.gov](https://www.sec.gov/Archives/edgar/data/840715/000175392626000897/clro-20260331.htm))

Sources:

GlobeNewswire, SEC

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CLRO Insider Trading Activity

$CLRO insiders have traded $CLRO stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CLRO stock by insiders over the last 6 months:

FINANCE LTD. FIRST purchased 437,500 shares for an estimated $1,750,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive CLRO Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CLRO Hedge Fund Activity

We have seen 3 institutional investors add shares of $CLRO stock to their portfolio, and 4 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

DRW SECURITIES, LLC removed 30,064 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $107,027
T3 COMPANIES, LLC added 30,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $106,800
SHAY CAPITAL LLC added 8,347 shares (+17.7%) to their portfolio in Q1 2026, for an estimated $29,715
GEODE CAPITAL MANAGEMENT, LLC added 3,205 shares (+30.2%) to their portfolio in Q1 2026, for an estimated $11,409
UBS GROUP AG removed 407 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,448
TOWER RESEARCH CAPITAL LLC (TRC) removed 76 shares (-10.6%) from their portfolio in Q1 2026, for an estimated $270
BANK OF AMERICA CORP /DE/ removed 8 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $28

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.